Atlas Trials

Fourth-generation Immucillin Derivative DI4G Associated Therapy in Cutaneous Leishmaniasis

Clinical trial NCT03294161 · COMPLETED

Trial details

NCT number
NCT03294161
Sponsor
Hospital Universitário Professor Edgard Santos
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
LeishmaniasisLeishmaniasis, CutaneousLeishmaniasis; American
Start date
2014-12-01
Primary completion
2017-04-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.